DKK: Key Regulator of Cell Signaling and Disease (P48428)

Target Name: Dickkopf protein

NCBI ID: P48428

Dickkopf protein

Other Name(s): DKK

DKK: Key Regulator of Cell Signaling and Disease

Dickkopf protein (DKK) is a protein that is expressed in various tissues throughout the body, including the brain, heart, liver, and pancreas. It is a key regulator of cell signaling, and its levels have been linked to a number of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

One of the key functions of DKK is its role in the regulation of ion channels, which are responsible for the flow of electrical signals through cells. DKK has been shown to play a key role in the regulation of the sodium (Na+) and potassium ( K+) channels, which are essential for the normal functioning of many different cell types.

In addition to its role in ion channel regulation, DKK has also been shown to play a number of other important functions. For example, it has been shown to play a key role in the regulation of cell adhesion, which is the process by which cells stick together to form tissues and organs. DKK has also been shown to be involved in the regulation of cell growth and differentiation, as well as in the regulation of cell death.

The levels of DKK have been linked to a number of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. For example, studies have shown that high levels of DKK are associated with an increased risk of neurodegenerative diseases, such as Alzheimer's and Parkinson's disease . Additionally, DKK has been shown to be involved in the development and progression of certain autoimmune disorders, such as rheumatoid arthritis and multiple sclerosis.

In addition to its potential as a drug target or biomarker, DKK is also of interest as a potential therapeutic approach for a number of different diseases. For example, studies have shown that inhibiting the activity of DKK has the potential to treat a number of different diseases. conditions, including cancer, neurodegenerative diseases, and autoimmune disorders. Additionally, DKK has been shown to be involved in a number of different signaling pathways, which makes it a potential target for small molecules that can be used to treat a wide range of diseases.

In conclusion, Dickkopf protein (DKK) is a protein that is expressed in various tissues throughout the body that is involved in a number of important functions, including cell signaling, ion channel regulation, cell adhesion, and cell growth and differentiation. Its levels have been linked to a number of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. Additionally, DKK is of interest as a potential drug target or biomarker, and has the potential to treat a number of different conditions. Further research is needed to fully understand the role of DKK in disease and to develop effective therapies.

Protein Name: Dickkopf Protein (nonspecified Subtype)

The "Dickkopf protein Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about Dickkopf protein comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets